Full Press Release Details
DUBLIN , July 22, 2015 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that it will report its 2015 second quarter financial results on Wednesday, August 5, 2015 , after the close of the financial markets. Company management will host a live audio webcast immediately following the announcement at 4:30 p.m. EDT / 9:30 p.m. IST to discuss 2015 second quarter financial results and provide a business and financial update.
Interested parties may access the live audio webcast via the Investors & Media section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com . Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast will be archived on the website for one week.
Audio webcast/conference call: U.S. Dial-In Number: +1 877 546 5019 International Dial-In Number: +1 857 244 7551 Passcode: 69329137
A replay of the conference call will be available through August 12, 2015 and accessible through one of the following telephone numbers, using the passcode below:
Replay U.S. Dial-In Number: +1 888 286 8010 Replay International Dial-In Number: +1 617 801 6888 Passcode: 47514310
About Jazz Pharmaceuticals Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) is an international biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing meaningful products that address unmet medical needs. The company has a diverse portfolio of products and/or product candidates with a focus in the areas of sleep and hematology/oncology. In these areas, Jazz Pharmaceuticals markets Xyrem® (sodium oxybate) oral solution and Erwinaze® (asparaginase Erwinia chrysanthemi ) in the U.S., and markets Erwinase® and Defitelio® (defibrotide) in Europe and other countries outside the U.S. For more information, please visit www.jazzpharmaceuticals.com .
SOURCE Jazz Pharmaceuticals plc